Skip to main content

Pfizer claims 3rd dose 'strongly' boosts protection against Delta variant

Share

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.

The data posted online, which are expected to be discussed in a company earnings call on Wednesday morning, suggest that antibody levels against the Delta variant in people ages 18 to 55 who receive a third dose of vaccine are greater than five-fold than following a second dose.

Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the Delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose.

There's "estimated potential for up to 100-fold increase in Delta neutralization post-dose three compared to pre-dose three," researchers wrote in the Pfizer data slides.

The data have not yet been peer-reviewed or published.

The data also show that antibody levels are much higher after a third dose than a second dose against the original coronavirus variant and the Beta variant, first identified in South Africa.

CTVNews.ca Top Stories

Search for Malaysia Airlines Flight 370 may resume

Malaysia's government said Sunday it may renew the hunt for missing Malaysia Airlines flight MH370 after a U.S. technology firm proposed a fresh search in the southern Indian Ocean where the plane is believed to have crashed a decade ago.

Stay Connected